Compounds transferred to BMS for further development…
Jan 3 (Reuters) - An experimental drug to combat amyotrophic lateral sclerosis, commonly called Lou Gehrig's disease in the United States, failed to work in an important trial and Biogen Idec said it…
Luke Timmerman Eli Lilly once made a fortune on a schizophrenia drug that helped a lot of people, but came with a nasty side effect—weight gain. Now Dublin, Ireland- and Waltham, MA-based Alke…
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (MRK), known outside the United States and Canada as MSD, today announced that the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce th…
